PMID
Cmpds
Data
Article Title
Organization
27
Benzoflavones as cholesterol esterase inhibitors: Synthesis, biological evaluation and docking studies.

Guru Nanak Dev University
23
Aurone Mannich base derivatives as promising multifunctional agents with acetylcholinesterase inhibition, anti-ß-amyloid aggragation and neuroprotective properties for the treatment of Alzheimer's disease.

Sichuan University
22
Multitarget drug design strategy against Alzheimer's disease: Homoisoflavonoid Mannich base derivatives serve as acetylcholinesterase and monoamine oxidase B dual inhibitors with multifunctional properties.

Sichuan University
19
Design, synthesis and evaluation of rivastigmine and curcumin hybrids as site-activated multitarget-directed ligands for Alzheimer's disease therapy.

Zhejiang University
28
Potent reversible anticholinesterase agents. Bis- and mono-N-substituted benzoquinolinium halides.

TBA
8
Synthesis and insecticidal activity of novel carbamate derivatives as potential dual-binding site acetylcholinesterase inhibitors.

Chinese Academy of Agricultural Sciences
21
Use of ab initio calculations to predict the biological potency of carboxylesterase inhibitors.

University of California
29
Carbamate derivatives of indolines as cholinesterase inhibitors and antioxidants for the treatment of Alzheimer's disease.

Bar-Ilan University
24
Synthesis and evaluation of novel 4-[(3H,3aH,6aH)-3-phenyl)-4,6-dioxo-2-phenyldihydro-2H-pyrrolo[3,4-d]isoxazol-5(3H,6H,6aH)-yl]benzoic acid derivatives as potent acetylcholinesterase inhibitors and anti-amnestic agents.

Punjabi University
15
Synthesis of phenserine analogues and evaluation of their cholinesterase inhibitory activities.

Meiji Pharmaceutical University
15
Multipotent MAO and cholinesterase inhibitors for the treatment of Alzheimer's disease: synthesis, pharmacological analysis and molecular modeling of heterocyclic substituted alkyl and cycloalkyl propargyl amine.

Laboratorio De Radicales Libres Y Qu�Mica Computacional (Iqog, Csic)
13
Cholinestrase inhibitory effects of geranylated flavonoids from Paulownia tomentosa fruits.

Graduate School of Gyeongsang National University
14
Novel donepezil-based inhibitors of acetyl- and butyrylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation.

Laboratori De Qu�Mica Farmac�Utica (Unitat Associada Al Csic)
58
Exploiting protein fluctuations at the active-site gorge of human cholinesterases: further optimization of the design strategy to develop extremely potent inhibitors.

University of Siena
11
Design and synthesis of tacrine-ferulic acid hybrids as multi-potent anti-Alzheimer drug candidates.

Friedrich-Schiller-Universit£T Jena
16
Influence of sulfur oxidation state and steric bulk upon trifluoromethyl ketone (TFK) binding kinetics to carboxylesterases and fatty acid amide hydrolase (FAAH).

University of California
1
Brunneins A-C, beta-carboline alkaloids from Cortinarius brunneus.

Institute of Plant Biochemistry
18
Derivatives of oxoisoaporphine alkaloids: a novel class of selective acetylcholinesterase inhibitors.

Sun Yat-Sen University
5
Propidium-based polyamine ligands as potent inhibitors of acetylcholinesterase and acetylcholinesterase-induced amyloid-beta aggregation.

University of Bologna
27
Design, synthesis, and evaluation of 2-phenoxy-indan-1-one derivatives as acetylcholinesterase inhibitors.

Zhejiang University
6
Pyridophens: binary pyridostigmine-aprophen prodrugs with differential inhibition of acetylcholinesterase, butyrylcholinesterase, and muscarinic receptors.

Institute of Research
42
Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-[(5,6-dimethoxy-1-oxoindan-2-yl)methyl]piperidine hydrochloride and related compounds.

Eisai
42
Synthesis and evaluation of 5-amino-5,6,7,8-tetrahydroquinolinones as potential agents for the treatment of Alzheimer's disease.

Hoechst-Roussel Pharmaceuticals
11
Potent, easily synthesized huperzine A-tacrine hybrid acetylcholinesterase inhibitors.

Hong Kong University of Science and Technology
5
Conformationally restricted carbamate inhibitors of horse serum butyrylcholinesterase.

National Chung-Hsing University
16
Benzenediol-berberine hybrids: multifunctional agents for Alzheimer's disease.

Guangzhou Institute of Biomedicine and Health
19
Formulating a new basis for the treatment against botulinum neurotoxin intoxication: 3,4-Diaminopyridine prodrug design and characterization.

The Scripps Research Institute
55
Homodimeric bis-quaternary heterocyclic ammonium salts as potent acetyl- and butyrylcholinesterase inhibitors: a systematic investigation of the influence of linker and cationic heads over affinity and selectivity.

Universidad De Granada
36
Design, synthesis and structure-activity relationship (SAR) studies of 2,4-disubstituted pyrimidine derivatives: dual activity as cholinesterase and A β-aggregation inhibitors.

University of Waterloo
18
Synthesis, biological evaluation and molecular modeling of novel triazole-containing berberine derivatives as acetylcholinesterase and β-amyloid aggregation inhibitors.

Sun Yat-Sen University
15
Design, synthesis and evaluation of novel tacrine-multialkoxybenzene hybrids as dual inhibitors for cholinesterases and amyloid beta aggregation.

Sun Yat-Sen University
13
Berberine derivatives, with substituted amino groups linked at the 9-position, as inhibitors of acetylcholinesterase/butyrylcholinesterase.

Sun Yat-Sen University
28
Multipotent drugs with cholinergic and neuroprotective properties for the treatment of Alzheimer and neuronal vascular diseases. I. Synthesis, biological assessment, and molecular modeling of simple and readily available 2-aminopyridine-, and 2-chloropyridine-3,5-dicarbonitriles.

Laboratorio De Radicales Libres Y QuíMica Computacional (Iqog, Csic)
16
Synthesis of physostigmine analogues and evaluation of their anticholinesterase activities.

Zhejiang University
26
Design, synthesis and evaluation of flavonoid derivatives as potent AChE inhibitors.

Zhejiang University
6
Acetylcholinesterase inhibition by tacrine analogues

TBA
24
Synthesis and anti-acetylcholinesterase activity of 1-benzyl-4-[(5,6-dimethoxy-1-indanon-2-yl)methyl]piperidine hydrochloride (E2020) and related compounds

TBA
13
The synthesis and
in vitro acetylcholinesterase and butyrylcholinesterase inhibitory activity of tacrine (Cognex®) derivaties

TBA
1
Site-activated multifunctional chelator with acetylcholinesterase and neuroprotective-neurorestorative moieties for Alzheimer's therapy.

Institute of Science
11
NO-donating tacrine hybrid compounds improve scopolamine-induced cognition impairment and show less hepatotoxicity.

Friedrich-Schiller-University Jena
28
2-Phenoxy-indan-1-one derivatives as acetylcholinesterase inhibitors: a study on the importance of modifications at the side chain on the activity.

Zhejiang University
20
Design, synthesis and evaluation of galanthamine derivatives as acetylcholinesterase inhibitors.

Zhejiang University
34
Design, synthesis and AChE inhibitory activity of indanone and aurone derivatives.

Zhejiang University
20
Design, synthesis and pharmacological evaluation of hybrid molecules out of quinazolinimines and lipoic acid lead to highly potent and selective butyrylcholinesterase inhibitors with antioxidant properties.

Friedrich-Schiller-UniversitäT Jena
5
Chemiluminescent high-throughput microassay applied to imidazo[2,1-b]thiazole derivatives as potential acetylcholinesterase and butyrylcholinesterase inhibitors.

Università
7
Methyl 2-(2-(4-formylphenoxy)acetamido)-2-substituted acetate derivatives: a new class of acetylcholinesterase inhibitors.

Sun Yat-Sen University
6
Review of bioactivity and structure-activity relationship on baicalein (5,6,7-trihydroxyflavone) and wogonin (5,7-dihydroxy-8-methoxyflavone) derivatives: Structural modifications inspired from flavonoids in Scutellaria baicalensis.

Shaanxi University of Chinese Medicine
42
Study on dual-site inhibitors of acetylcholinesterase: Highly potent derivatives of bis- and bifunctional huperzine B.

Chinese Academy of Sciences
10
Complexes of alkylene-linked tacrine dimers with Torpedo californica acetylcholinesterase: Binding of Bis5-tacrine produces a dramatic rearrangement in the active-site gorge.

Institute of Science
16
Homobivalent quinazolinimines as novel nanomolar inhibitors of cholinesterases with dirigible selectivity toward butyrylcholinesterase.

Friedrich-Schiller-UniversitäT Jena
101
Recent advance on carbamate-based cholinesterase inhibitors as potential multifunctional agents against Alzheimer's disease.

Lanzhou University
20
Development of naringenin-O-carbamate derivatives as multi-target-directed liagnds for the treatment of Alzheimer's disease.

Nanyang Normal University
10
Isolation and cholinesterase-inhibition studies of sterols from Haloxylon recurvum.

University of Karachi
8
Alzheimer's disease: Updated multi-targets therapeutics are in clinical and in progress.

Guizhou Medical University
11
Synthesis and acetylcholinesterase inhibition of derivatives of huperzine B.

Chinese Academy of Sciences
11
A tacrine-tetrahydroquinoline heterodimer potently inhibits acetylcholinesterase activity and enhances neurotransmission in mice.

The Hong Kong University of Science and Technology
4
Cage amines as the stopper inhibitors of cholinesterases.

National Chung-Hsing University
23
Design, synthesis and evaluation of novel dimethylamino chalcone-O-alkylamines derivatives as potential multifunctional agents against Alzheimer's disease.

Nanyang Normal University
40
Kinetics-Driven Drug Design Strategy for Next-Generation Acetylcholinesterase Inhibitors to Clinical Candidate.

Chinese Academy of Sciences
9
Design, synthesis, and pharmacological profile of novel fused pyrazolo[4,3-d]pyridine and pyrazolo[3,4-b][1,8]naphthyridine isosteres: a new class of potent and selective acetylcholinesterase inhibitors.

Universidade Federal Do Rio De Janeiro
26
Novel 3-benzylidene/benzylphthalide Mannich base derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.

Guizhou Medical University
14
Apigenin-rivastigmine hybrids as multi-target-directed liagnds for the treatment of Alzheimer's disease.

Nanyang Normal University
48
Pyridine alkaloids with activity in the central nervous system.

University of Auckland
33
Design, synthesis and evaluation of phthalide alkyl tertiary amine derivatives as promising acetylcholinesterase inhibitors with high potency and selectivity against Alzheimer's disease.

Guizhou Medical University
1
Discovery of 4'-OH-flurbiprofen Mannich base derivatives as potential Alzheimer's disease treatment with multiple inhibitory activities.

Sichuan University
21
Discovery of novel 2,5-dihydroxyterephthalamide derivatives as multifunctional agents for the treatment of Alzheimer's disease.

Sichuan University
14
Multi-target design strategies for the improved treatment of Alzheimer's disease.

China Pharmaceutical University
81
Anti-cholinesterase hybrids as multi-target-directed ligands against Alzheimer's disease (1998-2018).

Csir-Central Drug Research Institute
16
Multi-target-directed-ligands acting as enzyme inhibitors and receptor ligands.

Julius Maximilian University of W£Rzburg
9
Synthesis and comparison of the biological activity of monocyclic phosphonate, difluorophosphonate and phosphate analogs of the natural AChE inhibitor cyclophostin.

University of Missouri-St. Louis
16
Discovery of indanone derivatives as multi-target-directed ligands against Alzheimer's disease.

Sun Yat-Sen University
27
Novel benzisoxazole derivatives as potent and selective inhibitors of acetylcholinesterase.

Pfizer
29
Discovery of novel 2,6-disubstituted pyridazinone derivatives as acetylcholinesterase inhibitors.

Chinese Academy of Sciences
18
Homo- and hetero-dimers of inactive organophosphorous group binding at dual sites of AChE.

Chinese Academy of Agricultural Sciences
2
Development and biological activity of a new antagonist of the pheromone of the codling moth Cydia pomonella.

University of Lleida
19
Discovery of novel propargylamine-modified 4-aminoalkyl imidazole substituted pyrimidinylthiourea derivatives as multifunctional agents for the treatment of Alzheimer's disease.

East China University of Science and Technology
24
Design, synthesis and evaluation of vilazodone-tacrine hybrids as multitarget-directed ligands against depression with cognitive impairment.

East China University of Science and Technology
31
Design, synthesis and biological evaluation of phthalimide-alkylamine derivatives as balanced multifunctional cholinesterase and monoamine oxidase-B inhibitors for the treatment of Alzheimer's disease.

Nanyang Normal University
49
Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-(2-phthalimidoethyl)piperidine and related derivatives.

Eisai
99
Compounds and compositions as inhibitors of MEK

Novartis
14
Pyridazinones as DAAO enzyme inhibitors

Takeda Pharmaceutical
62
P2X7 modulators

Janssen Pharmaceutica
42
Quinolinone compound and use thereof

Sunshine Lake Pharma
13
Compounds for use in methods for treating diseases or conditions mediated by protein disulfide isomerase

Beth Israel Deaconess Medical Center
148
Pyridine derivative

Astellas Pharma
296
3-substituted 2-amino-indole derivatives

Takeda Pharmaceutical
136
Isoxazole compounds as inhibitors of heat shock proteins

The Institute of Cancer Research
29
Seven-membered ring compound and pharmaceutical use therefor

Daiichi Sankyo
28
Cyclohexyl amide derivatives as CRF receptor antagonists

Novartis
4
The mobility of a conserved tyrosine residue controls isoform-dependent enzyme-inhibitor interactions in nitric oxide synthases.

University of California Irvine
23
Chemical compounds

AstraZeneca
23
Cyclohexane derivative having NPY Y5 receptor antagonism

Shionogi
197
Peptidomimetic sulfamide compounds and antiviral uses thereof

Novartis
20
Synthesis and evaluation of c-Src kinase inhibitory activity of pyridin-2(1H)-one derivatives.

University of Delhi
29
Cycloalkyl-substituted imidazole derivative

Daiichi Sankyo
23
Trypsin-like serine protease inhibitors, and their preparation and use

The Medicines Company (Leipzig)
9
1,4-diaryl-pyrimidopyridazine-2,5-diones and their use

Bayer Intellectual Property
7
Tetrahydro-pyrazolo[1,5-a]pyrido-pyrimidines as antagonists of serotonin 5-HT6 receptors, methods for the production and use thereof

TBA
3
Methods of using 4, 5, 6, 7-tetrahydroimidazo-[4,5-c]pyridine compounds

Proximagen
103
Compounds and compositions as protein kinase inhibitors

Novartis
8
Substituted 4-(indazolyl)-1,4-dihydropyridines and methods of use thereof

Bayer Intellectual Property
7
Novel benzimidazole inhibitors bind to a unique site in the kinesin spindle protein motor domain.

Merck Research Laboratories
7
Genetic and pharmacological inhibition of PDK1 in cancer cells: characterization of a selective allosteric kinase inhibitor.

Merck Research Laboratories
8
Cisplatin inhibits protein splicing, suggesting inteins as therapeutic targets in mycobacteria.

University of Science and Technology of China
25
Discovery and SAR of 1,3,4-thiadiazole derivatives as potent Abl tyrosine kinase inhibitors and cytodifferentiating agents.

Universit&Aagrov
8
Computational study of antagonist/alpha1A adrenoceptor complexes--observations of conformational variations on the formation of ligand/receptor complexes.

University of Dublin
3
S33084, a novel, potent, selective, and competitive antagonist at dopamine D(3)-receptors: I. Receptorial, electrophysiological and neurochemical profile compared with GR218,231 and L741,626.

Centre De Recherches De Croissy
18
Characterization of human A(2B) adenosine receptors: radioligand binding, western blotting, and coupling to G(q) in human embryonic kidney 293 cells and HMC-1 mast cells.

University of Virginia
1
Functional effects of the muscarinic receptor agonist, xanomeline, at 5-HT1 and 5-HT2 receptors.

Smithkline Beecham Pharmaceuticals
12
Molecular pharmacology of homologues of ibotenic acid at cloned metabotropic glutamic acid receptors.

The Royal Danish School of Pharmacy
26
Pharmacology of [3H]prostaglandin E1/[3H]prostaglandin E2 and [3H]prostaglandin F2alpha binding to EP3 and FP prostaglandin receptor binding sites in bovine corpus luteum: characterization and correlation with functional data.

Alcon Laboratories
4
Nonpeptide endothelin receptor antagonists. XI. Pharmacological characterization of SB 234551, a high-affinity and selective nonpeptide ETA receptor antagonist.

Smithkline Beecham Pharmaceuticals
4
Characteristics of histamine H1 receptors on HeLa cells.

University of Cambridge
16
[3H]BIMU-1, a 5-hydroxytryptamine3 receptor ligand in NG-108 cells, selectively labels sigma-2 binding sites in guinea pig hippocampus.

Syntex Discovery Research
4
Cloning and expression of a human somatostatin-14-selective receptor variant (somatostatin receptor 4) located on chromosome 20.

University of Toronto
3
PET examination of [11C]NNC 687 and [11C]NNC 756 as new radioligands for the D1-dopamine receptor.

Karolinska Institutet
11
Cyclodextrin Inclusion Complexes: Studies of the Variation in the Size of Alicyclic Guests

University of Mississippi
16
7-Chloro-5-hydroxy-1-[2-methyl-4-(2-methylbenzoyl-amino)benzoyl ]-2,3,4,5-tetrahydro-1H-1-benzazepine (OPC-41061): a potent, orally active nonpeptide arginine vasopressin V2 receptor antagonist.

Otsuka Pharmaceutical
27
Discovery, SAR, and pharmacokinetics of a novel 3-hydroxyquinolin-2(1H)-one series of potent D-amino acid oxidase (DAAO) inhibitors.

Pfizer
5
Isofagomine- and 2,5-anhydro-2,5-imino-D-glucitol-based glucocerebrosidase pharmacological chaperones for Gaucher disease intervention.

The Scripps Research Institute
26
Synthesis and protein kinase C inhibitory activities of acyclic balanol analogs that are highly selective for protein kinase C over protein kinase A.

Sphinx Laboratories
30
Synthesis and evaluation of 2-pyridinone derivatives as specific HIV-1 reverse transcriptase inhibitors. 3. Pyridyl and phenyl analogs of 3-aminopyridin-2(1H)-one.

Merck Research Laboratories
24
Structure-based design, synthesis, and biological evaluation of conformationally restricted novel 2-alkylthio-6-[1-(2,6-difluorophenyl)alkyl]-3,4-dihydro-5-alkylpyrimidin-4(3H)-ones as non-nucleoside inhibitors of HIV-1 reverse transcriptase.

Sapienza University of Rome
41
Targeting delavirdine/atevirdine resistant HIV-1: identification of (alkylamino)piperidine-containing bis(heteroaryl)piperazines as broad spectrum HIV-1 reverse transcriptase inhibitors.

Upjohn
20
Structure-based design of novel HIV protease inhibitors: carboxamide-containing 4-hydroxycoumarins and 4-hydroxy-2-pyrones as potent nonpeptidic inhibitors.

Upjohn